If you don't understand the syllabus, you don't stand a chance in NEET SS Pathology. Most aspirants waste months studying random topics. The toppers study what actually gets asked. This page gives you the full topic-wise syllabus, high-yield areas, weightage insights based on past paper analysis, and a clear strategy for what to study versus what to skip.
The truth about NEET SS Pathology: The syllabus is based on your MD-level pathology knowledge, but tested at a much deeper, clinical + image-based level. Not all topics are equal — some topics dominate the paper every single year. This page shows you exactly which ones.
The syllabus is vast — but the exam is predictable if you know the pattern.
NEET SS Pathology is conducted by the National Board of Examinations in Medical Sciences (NBEMS) for admission to DM Oncopathology, DM Hematopathology, DM Cytopathology, and related super-specialty courses. The examination tests advanced knowledge in pathology — significantly beyond the MD level. NBEMS does not publish a line-by-line syllabus document, but the scope of the exam is well understood from official information bulletins and analysis of past papers.
The syllabus broadly covers six major domains:
Cell injury, inflammation, neoplasia, immunopathology, genetic disorders
Leukemias, lymphomas, myeloproliferative disorders, bone marrow pathology
GI, hepatobiliary, lung, breast, renal, endocrine, CNS, skin, GU, GYN
FNAC, Pap smear, fluid cytology, Bethesda system
PCR, FISH, NGS, IHC panels, tumour genetics, companion diagnostics
Transfusion medicine, coagulation, quality control, lab techniques
Your foundation. Questions here are conceptual but predictable — they test understanding of mechanism, not rote memory. General pathology forms the theoretical backbone that every systemic topic builds upon.
This is the king of the NEET SS Pathology syllabus. Alone, hematopathology contributes approximately 20–25% of the paper based on past trends. If you're weak here, your rank drops. Simple.
This is where the volume lives. Each system contributes multiple questions every year.
Often underestimated by candidates. Cytopathology is highly image-based — if you've practised the images, these become easy marks. If you haven't, you'll waste time guessing.
This area is increasing in weightage every year. If you're preparing for NEET SS 2026 or 2027, expect more questions from this domain than any previous year. This is also where the FRCPath Part 1 syllabus overlaps most directly.
This section is smaller in volume but highly predictable. The topics repeat frequently and are straightforward if you've revised them.
Based on analysis of past NEET SS papers — not guesswork.
NBEMS does not publish official topic weightage. The table below is based on analysis of past NEET SS Pathology papers and question patterns across multiple sittings. Use this as a strategic guide, not an absolute guarantee.
| Topic | Weightage | Visual | Trend |
|---|---|---|---|
| Hematopathology | Highest (~20–25%) | Consistently dominant | |
| GI & Hepatobiliary | High (~12–15%) | Stable, high every year | |
| Breast Pathology | High (~10–12%) | Stable | |
| CNS / Neuropathology | High (~8–12%) | Increasing | |
| Lung Pathology | High (~8–10%) | Increasing | |
| Molecular Pathology & IHC | Rising (~8–12%) | Fastest growing area | |
| General Pathology | Medium (~6–8%) | Stable | |
| Cytopathology | Medium (~5–8%) | Stable | |
| GU / Renal / GYN | Medium (~6–8%) | Stable | |
| Endocrine (Thyroid) | Medium (~4–6%) | Stable | |
| Lab Medicine | Moderate (~3–5%) | Predictable | |
| Dermatopathology / Soft Tissue | Low (~2–4%) | Low but present |
These topics repeat in some form every year. They are non-negotiable.
WHO 5th Ed subtypes, cytogenetics, molecular risk stratification
Hodgkin vs NHL panels, CD markers, molecular subtypes
ER/PR/HER2 scoring, molecular classification, Oncotype DX
IDH, ATRX, 1p/19q, TERT, EGFR — WHO 2021 integrated diagnosis
EGFR, ALK, ROS1, KRAS G12C, PD-L1, companion diagnostics
CIN vs MSI vs CIMP, Lynch screening, BRAF V600E
BRAF V600E, RAS, RET/PTC, NIFTP criteria, TERT promoter
CK7/CK20, TTF-1/CDX2, GATA3/PAX8 — carcinoma of unknown primary
Don't study like everyone else. Study like a topper.
Start with Hematopathology + Oncopathology. This alone covers ~40% of the paper. Use high-yield notes for structured coverage.
Finish GI → Breast → CNS → Lung → Thyroid in that order. Focus on WHO classification, IHC panels, and molecular markers for each system.
NEET SS is application-based — you need to recognise, not recall. Use the 800+ online MCQ bank for timed, exam-pattern practice.
30–40% of questions are image-based. Practise histopathology images, flow cytometry plots, and IHC staining patterns. This is where ranks are decided.
Avoid these traps — every year, candidates lose rank to predictable errors.
NEET SS isn't about what you studied — it's about what you can recognise in 30 seconds.
Studying dermpath and hemato equally is a strategic error. One is 25% of the paper, the other is 3%.
Reading without revision cycles means you forget 70% within 2 weeks. Build spaced repetition into your plan.
Reading textbooks without solving exam-pattern MCQs leaves you unprepared for the application-based format.
This is the fastest-growing section. Ignoring it costs you marks that your competitors are picking up.
Image interpretation takes months to build. Last-minute cramming doesn't work for pattern recognition.
Preparing for one? You're 90% ready for the other.
FRCPath Part 1 (Royal College of Pathologists, UK) and NEET SS Pathology share approximately 90% syllabus overlap. Both exams test advanced histopathology, IHC, molecular pathology, hematopathology, and oncopathology at a similar depth. The key differences are in exam format and UK-specific guidelines.
| Aspect | NEET SS Pathology | FRCPath Part 1 |
|---|---|---|
| Conducting body | NBEMS (India) | RCPath (UK) |
| Purpose | DM Oncopathology, DM Hematopathology admission | Fellowship of RCPath — consultant pathway |
| Core syllabus overlap | ~90% shared content | |
| Classification standard | WHO 5th Edition | WHO 5th Edition + RCPath Datasets |
| Molecular pathology | Increasing yearly | Already substantial |
| UK-specific guidelines | Not required | Required (NICE, RCPath datasets) |
| Exam format | MCQs (single day, computer-based) | SBAs/EMQs (varies by specialty) |
Built by practising pathologists. Designed for NEET SS, INI-SS, and FRCPath candidates.
Notes + 800+ MCQs + live recordings. Lifetime access.
Exam-pattern questions with concept explanations.
13 systems, WHO 5th Ed updated. Rapid revision.
Weekly Zoom sessions with Dr. Akshay Bali.
No login. No paywall. Direct download.
Common questions about the NEET SS Pathology syllabus.
The syllabus is not the problem. Everyone has the same syllabus.
The difference is how you prioritise, how you revise, and how you practise.
Explore the Full Course → Download Free 199 MCQs